Nestin expression correlates with nerve and retroperitoneal tissue invasion in pancreatic cancer.
Nestin was first described as an intermediate filament protein expressed in neuroepithelial stem cells. Nestin expression has also been reported in brain tumors, schwannomas, gastrointestinal stromal tumors, and melanomas. In the pancreas, Nestin expression has been detected in exocrine and mesenchymal cells, including stellate cells, pericytes, and endothelial cells. In the present study, we examined Nestin expression in human pancreatic ductal adenocarcinoma and sought to determine its role in this malignancy. Reverse transcription-polymerase chain reaction analysis demonstrated the presence of Nestin mRNA in all 10 tested pancreatic cancer cell lines, and quantitative reverse transcription-polymerase chain reaction revealed that Nestin mRNA levels were highest in PANC-1 cells and lowest in PK-8 cells. Immunofluorescent analysis revealed that Nestin localized in the outer cytoplasm of PANC-1 cells. Nestin immunoreactivity was present in the cancer cells in 20 (33.3%) of 60 cancer cases, and its expression was confirmed by in situ hybridization. Nestin expression was also increased in peripheral nerve fibers adjacent to cancer cells and in peripheral nerve fibers invaded by cancer cells. Clinicopathologically, there was a statistically significant association between Nestin expression in pancreatic cancer cells and nerve invasion (P = .010) and the presence of cancer cells in the tumor resection margins (P = .003). Nestin-positive cases exhibited similar survival after resection by comparison with Nestin-negative cases, irrespective of whether they were given adjuvant therapy. These findings indicate that Nestin expression in pancreatic cancer cells may contribute to nerve and stromal invasion in this malignancy.
Kawamoto
Masao
M
Surgery for Organ and Biological Regulation-Department of Surgery I, Graduate School of Medicine, Nippon Medical School, Tokyo 113-8603, Japan.
Ishiwata
Toshiyuki
T
Cho
Kazumitsu
K
Uchida
Eiji
E
Korc
Murray
M
Naito
Zenya
Z
Tajiri
Takashi
T
D000368:Aged; D021441:Carcinoma, Pancreatic Ductal / Q000378:metabolism / Q000401:mortality / Q000473:pathology*; D045744:Cell Line, Tumor; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D017403:In Situ Hybridization; D007381:Intermediate Filament Proteins / Q000096:biosynthesis*; D053208:Kaplan-Meier Estimate; D008297:Male; D018613:Microscopy, Confocal; D008875:Middle Aged; D009361:Neoplasm Invasiveness / Q000473:pathology*; D009367:Neoplasm Staging; D009419:Nerve Tissue Proteins / Q000096:biosynthesis*; D064231:Nestin; D010190:Pancreatic Neoplasms / Q000378:metabolism / Q000401:mortality / Q000473:pathology*; D010525:Peripheral Nerves / Q000473:pathology*; D012333:RNA, Messenger / Q000032:analysis; D012187:Retroperitoneal Space / Q000473:pathology; D020133:Reverse Transcriptase Polymerase Chain Reaction
D007381:Intermediate Filament Proteins; C577484:NES protein, human; D009419:Nerve Tissue Proteins; D064231:Nestin; D012333:RNA, Messenger
Cell. 1990 Feb 23;60(4):585-95
1689217
Am J Pathol. 2001 Mar;158(3):817-23
11238030
Exp Cell Res. 1994 Oct;214(2):447-58
7925640
Exp Neurol. 2002 Mar;174(1):89-95
11869037
Neurosci Lett. 2006 May 29;400(1-2):80-5
16529857
Int J Dev Biol. 1995 Dec;39(6):947-56
8901197
APMIS. 2002 Jun;110(6):499-507
12193211
Pancreas. 2006 May;32(4):360-8
16670618
Lab Invest. 2002 Mar;82(3):345-51
11896213
Am J Pathol. 1999 Sep;155(3):815-22
10487839
J Cell Sci. 1993 Dec;106 ( Pt 4):1291-300
8126108
Neurobiol Dis. 1995 Apr;2(2):79-85
8980011
Clin Cancer Res. 1997 Aug;3(8):1309-16
9815813
Cancer Res. 2007 Jan 15;67(2):501-10
17234757
Biochem Biophys Res Commun. 2000 Apr 29;271(1):116-9
10777690
Biochim Biophys Acta. 2001 Sep 21;1520(3):251-4
11566362
Cancer Res. 1992 Oct 1;52(19):5334-41
1382841
Proc Natl Acad Sci U S A. 2007 Mar 13;104(11):4437-42
17360542
Eur J Neurosci. 1997 Jan;9(1):65-75
9042570
Clin Cancer Res. 1999 Oct;5(10):2840-7
10537351
Histochem Cell Biol. 2002 Apr;117(4):371-7
11976910
J Cell Sci. 1998 Jul 30;111 ( Pt 14):1951-61
9645943
Cancer Res. 1994 Jan 15;54(2):354-6
8275467
Int J Oncol. 2007 Mar;30(3):593-603
17273760
J Histochem Cytochem. 2002 Feb;50(2):147-58
11799134
Cancer Res. 2007 Oct 1;67(19):9199-206
17909025
Neuromuscul Disord. 2004 Jul;14(7):421-8
15210165
Pathol Int. 2007 Sep;57(9):589-93
17685930
Am J Pathol. 1998 Jul;153(1):213-22
9665482
Cell Mol Life Sci. 2004 Oct;61(19-20):2510-22
15526158
Cancer Res. 2006 Apr 1;66(7):3802-12
16585207
Pathol Int. 2007 Feb;57(2):60-7
17300669
Differentiation. 1997 May;61(4):243-9
9203347
J Clin Pathol. 2008 Apr;61(4):467-73
17873113
Hepatology. 1999 Feb;29(2):520-7
9918930
CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66
17237035
FEBS Lett. 2004 May 7;565(1-3):195-202
15135078
N Engl J Med. 1992 Feb 13;326(7):455-65
1732772